Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2024 10:39 ET | Source: Research and Markets

Multiple Sclerosis Drug Pipeline Research Report 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive Landscape

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Multiple Sclerosis - Pipeline...
May 16, 2024 08:00 ET | Source: Research and Markets

Multiple Sclerosis Drugs Market Outlook 2024-2028, 2033 - A $48 Billion Global Opportunity Dominated by Biogen, Novartis, Roche, Bayer HealthCare, and Pfizer

Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global multiple sclerosis drugs...
May 10, 2023 09:15 ET | Source: SNS Insider pvt ltd

Multiple Sclerosis (MS) Market to Cross USD 28.21 Billion by 2030 due to Rising Prevalence of Multiple Sclerosis (MS) and Favorable Reimbursement Policies | Research by SNS Insider

Pune, May 10, 2023 (GLOBE NEWSWIRE) -- “The Multiple Sclerosis (MS) Market was valued at USD 23.2 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 2.2% over the...
May 03, 2023 10:53 ET | Source: Research and Markets

Global Multiple Sclerosis Treatment Market Report 2023: Sector is Projected to Reach $38.41 Million in 2031 at a CAGR of 4.3%

Dublin, May 03, 2023 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Treatment Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global...
February 15, 2023 09:00 ET | Source: Market Research Future

Multiple Sclerosis Treatment Market Size to Surpass USD 30.55 Billion by 2030 at 2.31% CAGR – Report by Market Research Future (MRFR)

New York, USA, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Multiple Sclerosis Treatment Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Multiple Sclerosis...
December 24, 2021 06:58 ET | Source: Research and Markets

Global Multiple Sclerosis Industry Review 2018-2020 with Forecasts to 2026 - Market Size by Country, Competitor Drug Sales, Market Shares, and More

Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This report provides...
April 14, 2021 05:08 ET | Source: Research and Markets

Worldwide Multiple Sclerosis Therapeutics Industry to 2027 - by Drug Class, Route of Administration, and Distribution Channel and Geography

Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class, Route of Administration, and Distribution...
May 07, 2020 06:29 ET | Source: Data Bridge Market Research

Multiple Sclerosis Market: 2020 Drivers, Restraints, Drug Class, Diagnosis, End-Users, Distribution Channel, Industry SWOT Analysis and Company Profiles Opexa Therapeutics, Inc, Actelion Pharmaceuticals Ltd

WILMINGTON, N.C., May 07, 2020 (GLOBE NEWSWIRE) -- Multiple Sclerosis Market Size, Status and Forecast 2020-2027 its latest research report released by Data Bridge Market Research. The market report...